SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-18-053533
Filing Date
2018-10-02
Accepted
2018-10-02 21:35:32
Documents
1
Period of Report
2018-09-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 9445
  Complete submission text file 0001209191-18-053533.txt   11954
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103591
SIC: 2834 Pharmaceutical Preparations

Mailing Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85
Business Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85 0044 (0) 20 7604 800
ASTRAZENECA AB (Reporting) CIK: 0000928966 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-38670 | Film No.: 181103592

Mailing Address 35 GATEHOUSE DRIVE WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE WALTHAM MA 02451 (781) 810-0120
Entasis Therapeutics Holdings Inc. (Issuer) CIK: 0001724344 (see all company filings)

IRS No.: 824592913 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations